BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16336284)

  • 1. Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials.
    Poolsup N; Leelasangaluk V; Jittangtrong J; Rithlamlert C; Ratanapantamanee N; Khanthong M
    J Clin Pharm Ther; 2005 Dec; 30(6):521-32. PubMed ID: 16336284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frovatriptan: a review of its use in the acute treatment of migraine.
    Sanford M
    CNS Drugs; 2012 Sep; 26(9):791-811. PubMed ID: 22900951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe.
    Cady R; Elkind A; Goldstein J; Keywood C
    Curr Med Res Opin; 2004 Sep; 20(9):1465-72. PubMed ID: 15383196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-dose ibuprofen in acute migraine treatment: systematic review and meta-analysis.
    Suthisisang C; Poolsup N; Kittikulsuth W; Pudchakan P; Wiwatpanich P
    Ann Pharmacother; 2007 Nov; 41(11):1782-91. PubMed ID: 17878396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
    MacGregor EA; Pawsey SP; Campbell JC; Hu X
    Gend Med; 2010 Apr; 7(2):88-108. PubMed ID: 20435272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose range-finding studies with frovatriptan in the acute treatment of migraine.
    Rapoport A; Ryan R; Goldstein J; Keywood C
    Headache; 2002 Apr; 42 Suppl 2():S74-83. PubMed ID: 12028323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.
    Savi L; Mogavero S; Egan CG
    Drug Des Devel Ther; 2014; 8():983-92. PubMed ID: 25092964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
    Géraud G; Spierings EL; Keywood C
    Headache; 2002 Apr; 42 Suppl 2():S93-9. PubMed ID: 12028325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.
    Allais G; Benedetto C
    Drug Des Devel Ther; 2016; 10():3225-3236. PubMed ID: 27757013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frovatriptan: pharmacological differences and clinical results.
    Rapoport AM
    Curr Med Res Opin; 2001; 17 Suppl 1():s68-70. PubMed ID: 12463282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD; Berner T; Tobin J; Xiang Q; Campbell JC
    Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD; Elkind AH; Schreiber C; Keywood C
    Neurology; 2004 Jul; 63(2):261-9. PubMed ID: 15277618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frovatriptan for the acute treatment of migraine: a dose-finding study.
    Goldstein J; Keywood C;
    Headache; 2002 Jan; 42(1):41-8. PubMed ID: 12005274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frovatriptan review.
    Markus F; Mikko K
    Expert Opin Pharmacother; 2007 Dec; 8(17):3029-33. PubMed ID: 18001261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies.
    Tullo V; Bussone G; Omboni S; Barbanti P; Cortelli P; Curone M; Peccarisi C; Benedetto C; Pezzola D; Zava D; Allais G
    Neurol Sci; 2013 May; 34 Suppl 1():S87-91. PubMed ID: 23695053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
    Guidotti M; Ravasio R
    Clin Drug Investig; 2009; 29(11):693-702. PubMed ID: 19813772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frovatriptan as preemptive treatment for fasting-induced migraine.
    Latsko M; Silberstein S; Rosen N
    Headache; 2011 Mar; 51(3):369-374. PubMed ID: 21269298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of frovatriptan: placebo-controlled studies.
    Ryan R; Géraud G; Goldstein J; Cady R; Keywood C
    Headache; 2002 Apr; 42 Suppl 2():S84-92. PubMed ID: 12028324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.
    Savi L; Omboni S; Lisotto C; Zanchin G; Ferrari MD; Zava D; Pinessi L
    J Headache Pain; 2011 Dec; 12(6):609-15. PubMed ID: 21842274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.